Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Playing the QQQQ with Terry and friends. -- Ignore unavailable to you. Want to Upgrade?

To: Stock2006 who wrote (944)	6/21/2005 8:57:01 AM
From: Walkingshadow	Respond to of 4814

Yes, TELK has an interesting an novel cancer treatment. But evidently the clinical trial has not produced any outcomes data yet, which is what you really want to know. They have a lot of surrogates that were reported about a month ago and the ASCO meetings. Interestingly, despite that modestly favorable news, the stock did not rally immediately, but waited another week or so. There are lots of soft-tissue tumor drugs now in various stages of clinical trials. There have been and will continue to be significant advances. Personally, if I was long TELK, I'd be looking to close the position sooner rather than later. I can't see a lot more upside here as I mentioned previously. T